Successful Remission of Evans Syndrome Associated with Graves' Disease by Using Propylthiouracil Monotherapy

Internal Medicine

Volumn 50, Issue 6, 2011, Pages 621-625

  Ushiki, Takashi ^a   Masuko, Masayoshi ^c   Nikkuni, Koji ^b   Terukina Yoshida, Jun ^b   Momotsu Nanba, Ayako ^b   Morikawa, Hiroshi ^b   Akio, Usami ^d   Ichiro, Fuse ^c   Toba, Ken ^a   Takai, Kazue ^b   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA CITY GENERAL HOSPITAL   (Japan)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^d Usami Clinic   (Japan)

Author keywords

Disease; Evans syndrome; Graves'; Propylthiouracil; Soluble IL 2 receptor

Indexed keywords

PROPYLTHIOURACIL;

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; FEMALE; GRAVES DISEASE; HUMAN; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; FEMALE; GRAVES DISEASE; HUMANS; PROPYLTHIOURACIL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 84857070710     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4319     Document Type: Article

References (23)

1. Evans RS, Takahashi K, Duane RT, Payne R, Liu C. Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology. AMA Arch Intern Med 87: 48–65, 1951.
2. Dhingra KK, Jain D, Mandal S, Khurana N, Singh T, Gupta N. Evans syndrome: A study of six cases with review of literature. Hematology 13: 356–360, 2008.
3. Norton A, Roberts I. Management of Evans syndrome. Br J Haematol 132: 125–137, 2006.
4. Kuroda H, Kida M, Watanabe H, Matsunaga T, Niitsu Y, Matsumoto M. Basedow disease associated with Evans syndrome. Rinsho Ketsueki 46: 1118–1122, 2005 (in Japanese).
5. Yashiro M, Nagoshi H, Kasuga Y, et al. Evans' syndrome associated with Graves' disease. Intern Med 35: 987–990, 1996.
6. Shimohakamada Y, Fukuda N, Shinohara K, Inoue Y. Simultaneous occurrence of Basedow's disease and autoimmune hemolytic anemia. Rinsho Ketsueki 42: 328–331, 2001 (in Japanese).
7. Ikeda K, Maruyama Y, Yokoyama M, et al. Association of Graves' disease with Evans' syndrome in a patient with IgA nephropathy. Intern Med 40: 1004–1010, 2001.
8. Scaradavou A, Bussel J. Evans syndrome. Results of a pilot study utilizing a multiagent treatment protocol. J Pediatr Hematol Oncol 17: 290–295, 1995.
9. Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA. High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. Blood 100: 704–706, 2002.
10. Michel M, Chanet V, Dechartres A, et al. The spectrum of Evans syndrome in adults: New insight into the disease based on the analysis of 68 cases. Blood 114: 3167–3172, 2009.
11. Lechner K, Jager U. How I treat autoimmune hemolytic anemias in adults. Blood 116: 1831–1838, 2010.
12. Robak T, Robak P. Treatment options for autoimmune cytopenias. Transfus Med Hemother 31: 332–340, 2004.
13. Biro E, Szekanecz Z, Czirjak L, et al. Association of systemic and thyroid autoimmune diseases. Clin Rheumatol 25: 240–245, 2006.
14. McGregor AM, Petersen MM, McLachlan SM, Rooke P, Smith BR, Hall R. Carbimazole and the autoimmune response in Graves' disease. N Engl J Med 303: 302–307, 1980.
15. Michalek K, Morshed SA, Latif R, Davies TF. TSH receptor autoantibodies. Autoimmun Rev 9: 113–116, 2009.
16. Sato A, Zakarija M, McKenzie JM. Characteristics of thyrotropin binding to bovine thyroid plasma membranes and the influence of human IgG. Endocr Res Commun 4: 95–113, 1977.
17. Cooper DS. Antithyroid drugs. N Engl J Med 352: 905–917, 2005.
18. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Chrousos GP, Koutras DA. Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease. Thyroid 10: 527–532, 2000.
19. Zantut-Wittmann DE, Tambascia MA, da Silva Trevisan MA, Pinto GA, Vassallo J. Antithyroid drugs inhibit in vivo HLA-DR expression in thyroid follicular cells in Graves' disease. Thyroid 11: 575–580, 2001.
20. Lamberg BA, Kivikangas V, Pelkonen R, Vuopio P. Thrombocytopenia and decreased life-span of thrombocytes in hyperthyroid-ism. Ann Clin Res 3: 98–102, 1971.
21. Ogihara T, Katoh H, Yoshitake H, Iyori S, Saito I. Hyperthyroid-ism associated with autoimmune hemolytic anemia and periodic paralysis: A report of a case in which antihyperthyroid therapy alone was effective against hemolysis. Jpn J Med 26: 401–403, 1987.
22. Zwirska-Korczala K, Berdowska A, Jochem J, et al. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders. J Clin Pharm Ther 29: 151–156, 2004.
23. Fagiolo E, Vigevani F, Pozzetto U. High cytokine serum levels in patients with autoimmune hemolytic anemia (AIHA). Immunol Invest 23: 449–456, 1994.